Featured Physicians Featured Physicians
In the News In the News
Hospitals, Facilities and Services Hospitals, Facilities and Services
US Family Health Plan US Family Health Plan
Outpatient Services Outpatient Services
Health Information Health Information
Health and Fitness Tools Health and Fitness Tools
Calendar of Events Calendar of Events
Medical Education Medical Education
Research & Clinical Trials Research & Clinical Trials




       



Health Information

Health Information

Back to Health Library   Print This Page Print    Email to a Friend Email
Cevimeline hydrochloride for Sjögren's syndrome

Cevimeline hydrochloride for Sjögren's syndrome

Examples

Brand NameGeneric NameChemical Name
Evoxaccevimeline hydrochloride

Evoxac is given orally as a 30 mg capsule. Dosages vary from 1 to 3 capsules a day.

How It Works

Cevimeline stimulates the moisture-producing glands to increase saliva and tear production over a sustained period of time.

Why It Is Used

Cevimeline is used to treat symptoms of dry mouth and eyes caused by Sjögren's syndrome.

You should not take cevimeline if you have:

  • Uncontrolled asthma.
  • Narrow-angle glaucoma or inflammation of the iris.

How Well It Works

Studies show that cevimeline improves symptoms of dry mouth and eyes.1, 2

Side Effects

Side effects from cevimeline may include:

  • Excessive sweating.
  • Nausea.
  • Runny nose.
  • Diarrhea.
  • More frequent urination.

See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)

What To Think About

Talk to your doctor before taking cevimeline if you have:

  • History of heart disease.
  • Asthma.
  • Chronic bronchitis.
  • Chronic obstructive pulmonary disease (COPD).
  • Kidney problems.

If you are breast-feeding, pregnant, or trying to become pregnant, talk to your doctor before taking cevimeline.

Before taking cevimeline, review with your doctor all medicines that you take, both prescription and nonprescription.

Complete the new medication information form (PDF) Click here to view a form. (What is a PDF document?) to help you understand this medication.

References

Citations

  1. Fife RS, et al. (2002). Cevimeline for the treatment of xerostomia in patients with Sjögren's syndrome. Archives of Internal Medicine, 162: 1293-1300.

  2. Petrone D, et al. (2002). A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis and Rheumatism, 46(3): 748-754.

Credits

AuthorShannon Erstad, MBA/MPH
EditorKathleen M. Ariss, MS
Associate EditorPat Truman, MATC
Primary Medical ReviewerMartin Gabica, MD - Family Medicine
Specialist Medical ReviewerStanford M. Shoor, MD - Rheumatology
Last UpdatedMay 6, 2008